Hypertension and risk of brain metastasis from small cell lung cancer: A retrospective follow-up study

Anticancer Research

Volumn 24, Issue 5 B, 2004, Pages 3115-3120

  Sahmoun, Abe E ^a,b   Case, L Douglas ^c   Chavour, Sudhir ^a,b   Kareem, Sohail ^a,b   Schwartz, Gary G ^c  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Department of Medicine ^*

Author keywords

Brain; Hypertension; Metastasis; Small cell lung cancer

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRAIN METASTASIS; CANCER LOCALIZATION; CANCER RISK; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERTENSION; LUNG SMALL CELL CANCER; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

AGE FACTORS; AGED; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; CEREBROVASCULAR CIRCULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TELENCEPHALON;

EID: 6344285571     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Posner JB and Chernik NL: Intracranial metastases from cancer. Adv Neurol 19: 579-592, 1978.
2. Walker AE, Robins M and Weinfeld FD: Epidemiology of brain tumors: The national survey of intracranial neoplasms. Neurology 35: 219-226, 1985.
3. Wingo PA, Tong T and Bolden S: Cancer statistics. CA Cancer J Clin 45: 8-30, 1995.
4. Takakura K, Sano K, Hoho S et al: Metastatic Tumors of the Central System Nervous. Tokyo: Igaku-Shoin, 1982.
5. Baker AB: Metastatic tumors of the nervous system. Arch Pathol Lab Med 34: 495-537, 1942.
6. Baker GS, Kernohan JW and Kiefer EJ: Metastatic tumors of the brain. Surg Clin North Am 31: 1143-1145, 1951.
7. Chang DB, Yang PC, Luh KT et al: Late survival of non-small cell lung cancer patients with brain metastases: Influence of treatment. Chest 101: 1293-1297, 1992.
8. Lang EF and Slater J: Metastatic brain tumors. Results of surgical and nonsurgical treatment. Surg Clin North Am 44: 865-872, 1964.
9. Le Chevalier T, Smith FP, Caille P et al: Sites of primary malignancies in patients presenting with cerebral metastases: A review of 120 cases. Cancer 56: 880-882, 1985.
10. MacGee EE: Surgical treatment of cerebral metastases from lung cancer: The effect on quality and duration of survival. J Neurosurg 35: 416-420, 1971.
11. Markesbery WR, Brooks WH, Gupta GD et al: Treatment for patients with cerebral metastases. Arch Neurol 35: 754-756, 1978.
12. Sundaresan N and Galicich JH: Surgical treatment of brain metastases: Clinical and computerized tomography evaluation of the results of treatment. Cancer 55: 1382-88, 1985.
13. Zimm S, Wampler GL, Stablein D et al: Intracerebral metastases in solid-tumor patients: Natural history and results of treatment. Cancer 48: 384-394, 1981.
14. Sheehan RG: Southwestern internal medicine conference: Small cell lung cancer: a problem of tumor heterogeneity. Am J Med Sci 292(4): 241-256, 1986.
15. Newman SJ and Hansen HH: Frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma. Cancer 33: 492-496, 1974.
16. Auerbach O et al: Histologic type of lung cancer in relation to smoking habits, year of diagnosis and sites of metastases. Chest 67: 382-387, 1975.
17. Martini N et al: Oat cell carcinoma of the lung. Clin Bull 5: 144-148, 1975.
18. Matthews MJ: Problems in morphology and behavior of bronchopulmonary malignant disease. In: Lung Cancer, Natural History, Prognosis and Therapy, Isreal L and Chahinian AP, New York, Academic Press. 1976, pp 28-62.
19. Takita H et al: Small cell carcinoma of the lung: Clinicopathological studies. J Thor Cardiovasc Surg 66: 472-477, 1973.
20. Watson WL and Berg JW: Oat cell lung cancer. Cancer 15: 759-767, 1962.
21. Nugent JL, Bunn PA Jr, Matthews MJ et al: CNS metastases in small cell bronchogenic carcinoma: Increasing frequency and changing pattern with lengthening survival. Cancer 44: 1885-93, 1979.
22. Rosen S, Makuch R, Lichter A, Ihde D, Matthews M, Minna J, Glatstein E and Bunn P: Role of prophylactic cranial irradiation in prevention of CNS metastases in SCLC. Am J Med 74: 615-623, 1983.
23. Markesbery WR, Brooks WH, Gupta GD et al: Treatment for patients with cerebral metastases. Arch Neurol 35: 754-756, 1978.
24. Postmus PE, Haaxma-Reiche H, Smit EF et al: Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy-a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 18(19): 3400-8, 2000.
25. Delattre JY, Krol G, Thaler HT and Posner JB: Distribution of brain metastases. Arch Neurol 45: 741-744, 1988.
26. Erwing J: Metastasis in Neoplastic Disease. 3rd ed., chapt. 4, Saunders, Philadelphia, 1928.
27. Weiss L, Haydock D, Pickren JW and Lane WW: Organ vascularity and metastatic frequency. Am J Path 101: 101-113, 1980.
28. Virdis R, Balestrazzi P, Zampolli M et al: Hypertension in children with neurofibromatosis. Human Hypertension 8: 395-397, 1994.
29. Glantz MJ, Choy H and Yee L: Prophylactic cranial irradiation in small cell lung cancer: rationale, results, and recommendations. Semin Oncol 24(4): 477-483, 1997.
30. Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission. Cochrane Database Syst. Rev 4: CD002805, 2000.
31. Seventh Joint National Committee (JNC7) on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National institutes of Health, 2003.
32. World Health Organization. International Classification of Diseases. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Ninth Revision. Vol. 1 Geneva: World Health Organization; 1977.
33. Cox DR: Regression models and life-tables. J R Stat Soc 34B: 187-220, 1986.
34. Nussberger J: Investigating mineralocorticoid hypertension. J Hypertens Suppl 21(2): S25-30, 2003.
35. Chou CM: Evaluation and treatment of hypertension. Rheum Dis Clin North Am 25(3): 521-37, 1999.
36. Nugent MJ, Bunn PA, Matthews MJ et al: CNS metastases in small cell bronchogenic carcinoma: Increasing frequency and changing pattern with lengthening survival. Cancer 44: 1885-93, 1979.
37. King AB and Ford FR: Clinical and anatomical study of neurological conditions resulting from metastases in CNS due to carcinoma of lung: review of 100 cases. Bull Johns Hopkins Hosp 70: 124-156, 1942.
38. Halpert B, Fields WS and De Bakey ME: Intracranial metastasis from carcinoma of lung. Surgery 35: 346-349, 1954.
39. Galluzzi S and Payne PM: Bronchial carcinoma: statistical study of 741 necropsies with special reference to distribution of blood-borne metastases. Br J Cancer 9: 511-527, 1955.
40. Simionescu MD: Metastatic tumors of the brain. A follow-up study of 195 patients with neurosurgical considerations. J Neurosurg 17: 361-373, 1960.
41. Haar F and Patterson RH: Surgery for metastatic intracranial neoplasm. Cancer 30: 1241-1245, 1972.
42. Ries LA: Influence of extent of disease, histology, and demographic factors on lung cancer survival in the SEER population-based data. Semin Surg Oncol 10(1): 21-30, 1994.
43. Parkash O: Lung cancer: A statistical study based on autopsy data from 1928 to 1972. Respiration 34: 295-304, 1977.
44. Fisher ER, Hellstrom HR and Fisher B: Experimental study of relationship between hypertension and tumor growth and metastases. Br J Cancer 22(2): 342-345, 1968.
45. Lang EF and Slater J: Metastatic brain tumors. Results of surgical and nonsurgical treatment. Surg Clin North Am 44: 865-872, 1964.
46. Fidler IJ, Gersten DM and Hart IR: The biology of cancer invasion and metastasis. Adv Cancer Res 28: 149, 1978.
47. Fidler IJ: The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer 9: 223, 1973.
48. Hart IR: Seed and Soil revisited: mechanisms of site-specific metastasis. Cancer Metastasis Rev 1: 5, 1982.
49. Fidler IJ, Naito S and Pathak S: Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice. Cancer Metastasis Rev 9: 149, 1990.
50. Fidler IJ: Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of cancer metastasis. Cancer metastasis Rev 10: 229, 1991.
51. Radinsky R: Paracrine growth regulation of human colon carcinoma organ-specific metastases. Cancer Metastasis Rev 12: 345, 1993.
52. Radinsky R, Risin S, Fan et al: Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1: 19, 1995.
53. Price JE, Natio S and Fidler IJ: Growth in an organ microenvironment as a selective process in metastasis. Clin Exp Metastasis 6: 91, 1988.
54. Sutherland RM: Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240: 177, 1988.
55. Scheinok PA, Engler PE, Robertson PD, Hutter RVP and Henson DE: Lung cancer: Difference in age at diagnosis between men and women. N J Med 86(12): 951-7, 1989.
56. Greenberg ER, Korson R, Baker J, Barrett J, Baron JA and Yates J: Incidence of lung cancer by cell type: A population based study in New Hampshire and Vermont. JNCI 72(3): 599-603, 1984.